Replies to post #235506 on Anavex Life Sciences Corp (AVXL)

[WolfofMia]

Clearly the metrics they are publishing are good ones but would like to see the whole package if they exist.

Clearly Biogen doesn't know what the full package is either.

[Investor2014]

It would provide further assurance to me if I saw the results and they were good.

That sort of information is only available for a fee to investment group members. We of course have it, but not FOC!

[timberwolf7]

actually, just cause SAVA is looking at them and trying to influence them does NOT mean they will lead to anything when the P3 is finally run...

Maybe the better question is, why do folks BELIEVE this one works, WHY should we believe AVNX management...

(PS: just a guess that you are also on the SAVA IV board)

[TempePhil]

Cape cod, look at the anavex.com website. Find the presentations. They give good data and charts for results and biomarkers. A2-73 is not as oriented towards plaque reduction, but as the best (in many cases only successful)drug for AD and many other CNS diseases, pushing the frontiers of cns knowledge, new biomarkers have been discovered and old ones are being better quantified.

[XenaLives]

Well considering those drugs have a 99% failure rate it doesn't disturb me that Anavex is doing it differently. Their biomarkers actually track patients who are getting well.

Anavex 2-73 isn't an Alzheimer's drug, it's a CNS and perhaps an all-body health drug.

Eventually there will be some scientific publications dealing with those biomarkers, but I prefer the ones that Anavex has chosen.

They are kinda important and the ones Biogen and other Alzheimer’s drug companies track.